EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Ebos Group's enterprise value is A$7,706 Mil.
Ebos Group's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was A$581 Mil. Therefore, Ebos Group's EV-to-EBITDA for today is 13.27.
The historical rank and industry rank for Ebos Group's EV-to-EBITDA or its related term are showing as below:
ASX:EBO'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 8.74 Med: 13.35 Max: 21.09
Current: 13.48
During the past 13 years, the highest EV-to-EBITDA of Ebos Group was 21.09. The lowest was 8.74. And the median was 13.35.
ASX:EBO's EV-to-EBITDA is ranked worse than 71.25% of 80
companies
in the Medical Distribution industry
Industry Median: 10.23
vs ASX:EBO: 13.48
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
As of today (2024-05-06), Ebos Group's stock price is A$32.18.
Ebos Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was A$1.352. Therefore, Ebos Group's PE Ratio for today is 23.80.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.
Ebos Group EV-to-EBITDA Historical Data
The historical data trend for Ebos Group's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Ebos Group's EV-to-EBITDA
For the Medical Distribution subindustry, Ebos Group's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ebos Group's EV-to-EBITDA Distribution in the Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Ebos Group's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Ebos Group's EV-to-EBITDA falls into.
Ebos Group EV-to-EBITDA Calculation
Ebos Group's EV-to-EBITDA for today is calculated as:
Ebos Group's current Enterprise Value is A$7,706 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Ebos Group's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was A$581 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ebos Group (ASX:EBO) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Ebos Group's share price for today is A$32.18.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Ebos Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was A$1.352.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.
Thank you for viewing the detailed overview of Ebos Group's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
Ebos is the largest pharmaceutical wholesaler and distributor across Australia and New Zealand. It services community pharmacies and hospitals, which contribute around 60% and 30% of revenue respectively. Drug pricing and wholesale margins for PBS medicine are governed by the Australian government's Pharmaceutical Benefits Scheme, or PBS. Wholesale gross margins are capped at 7% for community pharmacy and 10% for hospitals, and ongoing price reform typically results in low single digit revenue growth. Aside from pharma distribution, Ebos operates an animal health product wholesale, manufacturing and retail business, as well as undertaking third party logistics services. These segments are smaller contributors to group revenue but due to the unregulated nature are higher-margin operations.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ASX:EBO has been successfully added to your 